GILD vs MHH · P/E 18, rev $7.80B vs P/E 43, rev $41.4M
Gilead Sciences Inc (GILD) versus Mastech Holdings Inc (MHH) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Mastech Holdings Inc (MHH) is a staffing & employment services company listed on US.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported MHH revenue for 2026-06-30 was $41.4M. Net income was -$100.0K. Revenue was up 0.9% from 2026-03-31 to 2026-06-30. MHH currently screens at market cap $85.8M and trailing P/E 42.9.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. MHH currently screens at market cap $85.8M and trailing P/E 42.9.
Not investment advice. Open the GILD and MHH stock pages for the full models.
Not investment advice.